Elena drove east from Portmouth with the USB drive tucked into her bra and the black sedan hanging two cars behind her like a patient shark. She took surface roads through a string of dying farm towns, past grain elevators and boarded-up feed stores and churches whose signs promised salvation but whose parking lots held only rusted pickups. The sedan stayed back, never closing, never losing sight of her taillights. It didn't need to intercept her. It only needed to remind her that she was visible.
She pulled into a truck stop outside a town called Gresham and parked between two eighteen-wheelers, their engines rumbling at idle. Inside, she bought a map, a prepaid data card, and a cup of coffee that tasted like it had been brewed during the previous administration. She found a corner booth with her back to the wall and a sightline to the door, then connected the USB drive to her phone again.
The directory labeled Subject Data contained two hundred and fourteen individual folders, each named with an inmate number and a harvest date. She found Stefan's file by searching his DOC number, the one she'd memorized during the years of appeals. S-VOSS-8842. Harvest date: January 15, 2025. She opened it.
The file contained a medical intake form, a consent document signed in Stefan's handwriting, a series of blood work results, and a final report titled *Extraction Summary – Protocol N-C7-44.* The report was signed by Dr. Lina Coyle. It described Stefan as a "viable subject" whose thanatopeptin levels measured at "787 ng/mL, exceeding threshold for commercial synthesis." It noted that extraction had been completed at 5:47 a.m., and that the subject had expired at 5:58 a.m. due to "acute cardiorespiratory failure secondary to chemical stress response." The body had been transferred to the viewing room at 6:10 a.m.
The clinical language made her want to vomit. She forced herself to keep reading, scrolling through the chemical assay reports, the shipment tracking numbers, the chain of custody forms that traced her brother's cerebrospinal fluid from a prison cell to a processing facility in Delmarre to a distribution center that shipped vials of Mnemexa to private clinics in six states.
At the bottom of the file was a single sentence in red text: *Subjects who expire during the observation period shall be classified as natural-cause fatalities, exempt from routine autopsy under COR-19(b).* The exact language she'd seen in the redacted memorandum. The language of the End-of-Life Dignity Act, the progressive reform that had been praised in op-eds and celebrated at humanitarian galas.
She closed the file and sat motionless for a long moment, the truck stop noise washing over her—the clatter of dishes, the murmur of drivers, the hiss of the coffee machine. Then she searched the USB drive for the name Coyle and found a personnel file that was not supposed to exist.
Dr. Lina Coyle, age fifty-one. Medical degree from Harkness University. Board-certified in neurology and clinical pharmacology. Joined HelixGen Corporation twelve years ago as a senior researcher in the Neurodegenerative Disease Division. Promoted to Director of Special Projects eight years ago. Primary architect of the Thanatos Project, including the synthetic trigger compound designated Protocol Chimera. Current base of operations: Ironwood State Penitentiary Medical Transition Unit.
The file included a photograph. Coyle was a narrow-faced woman with steel-gray hair pulled back in a severe bun, her eyes the color of slate behind rimless glasses. She wore a white coat over a dark blouse, and her expression was utterly neutral—neither warm nor cold, simply assessing. She looked like a woman who had long ago decided that the ends justified the means, and who had stopped thinking about the means at all.
Below the photograph was a section labeled Psychological Profile. Elena read it twice, the words blurring and sharpening in turns.
Subject Coyle demonstrates a Type II utilitarian ethical framework with minimal affective empathy. She views the Thanatos Project as a moral imperative, arguing that the suffering of condemned prisoners—who would die regardless of intervention—is ethically negligible when weighed against the potential to reverse dementia in millions of patients. She has repeatedly described the protocol as "the most efficient allocation of terminal human resources ever devised." Recommend continued observation but no intervention; her commitment to the project's stated humanitarian goals makes her an unlikely security risk.
Elena set the phone down. Coyle was not a sadist. She was something more frightening: a true believer. A woman who had looked at the machinery of capital punishment and seen not justice or cruelty but raw material, waiting to be refined. And she had been given the resources, the legal cover, and the institutional blessing to build an entire industry on that insight.
The black sedan was still in the truck stop parking lot when Elena walked back outside. She had a choice. She could drive to The Sentinel's offices in Portmouth and hand everything to Julian Riggs, hoping that HelixGen's dossier on him was just a threat and not a guarantee. Or she could go back to Ironwood—to the source, to Coyle, to the one person who could confirm or deny everything Petra had told her.
The decision made itself. Riggs was a journalist. Coyle was the story. And Elena had spent eighteen months learning that the only way to survive a lie was to walk straight into it.
She drove north, toward Ironwood, toward the blue-painted walls of the Medical Transition Unit and the woman who had signed her brother's death certificate with the same hand that had guided the needle.
The Ironwood visitor center was busier than it had been on the morning of Stefan's death. Families waited on plastic chairs, clutching clear bags of permitted items. Lawyers in cheap suits conferred with clients through reinforced glass. A television mounted in the corner played a news segment about the End-of-Life Dignity Act, praising its expansion to twelve new facilities. The governor's face appeared on screen, his smile broad and practiced. "This is what compassionate justice looks like," he said. "We're leading the nation in humane corrections reform."
Elena approached the check-in desk and asked for Dr. Coyle. The officer on duty, a different man from the soft-faced guard she'd encountered before, told her that Coyle didn't take visitors. She slid a folded piece of paper across the counter—a printout of the red text from Stefan's file, the exemption clause, the words natural-cause fatalities underlined in her own handwriting.
"Tell her Elena Voss wants to discuss Protocol N-C7-44. I'll wait."
The officer disappeared into a back office. Ten minutes passed. Twenty. The television cycled through a segment on falling crime rates, a weather forecast, a pharmaceutical commercial for Mnemexa that showed an elderly woman recognizing her daughter for the first time in years. "Ask your doctor about Mnemexa. Because every memory matters." Elena watched the commercial with her hands clenched in her lap, her fingernails cutting crescents into her palms.
The officer returned. "Dr. Coyle will see you. Follow me, please."
She was led through a different set of corridors than before—past the Medical Transition Unit's blue walls, through a security door that required both a badge and a retinal scan, into a wing that was quieter and cleaner and more expensively appointed than anything she'd seen at Ironwood. The air smelled of ozone and rubbing alcohol, the same faint metallic tang she'd noticed on her first visit. The walls were lined with photographs of the prison's humanitarian awards, certificates of recognition from medical ethics boards, a framed letter from the governor commending Ironwood's "innovative approach to end-of-life care."
Coyle's office was at the end of the hall, behind a door marked Director of Clinical Research. The woman herself sat behind a desk that was meticulously organized, its surface holding only a computer monitor, a telephone, and a single manila folder with no label. She looked exactly like her photograph—narrow face, gray hair, rimless glasses, an expression of detached assessment that made Elena feel like a specimen on a slide.
"Ms. Voss. Please sit." Coyle's voice was calm, unhurried, the voice of a doctor delivering a routine diagnosis. "I was sorry to hear about your brother. He was a cooperative participant in our program. His contribution to neurological science was genuinely significant."
"His contribution." Elena remained standing. "You make it sound like he donated a kidney."
"In a sense, he did. The compound we extracted from his cerebrospinal fluid will be used to manufacture approximately forty doses of Mnemexa. Each dose has the potential to restore six to eight months of cognitive function in a patient with advanced dementia. By any utilitarian calculus, your brother's death will extend meaningful life for dozens of people who would otherwise lose themselves to neurodegeneration. I understand this is difficult to hear, but the mathematics are unambiguous."
Elena felt the floor tilt beneath her. Coyle was not denying anything. She was not deflecting, not stonewalling, not threatening. She was explaining, in the same tone a professor might use to walk a student through a difficult equation. The candor was more disorienting than any lie could have been.
"You killed him. You injected him with a compound that induced terror so severe his heart stopped."
"We administered a calibrated chemical trigger designed to stimulate the hypothalamic-pituitary-adrenal axis. The cardiac event was an unintended complication. The protocol has since been refined." Coyle opened the manila folder on her desk and turned it around so Elena could see the contents. A consent form. Stefan's signature. A document titled *Informed Consent for Compassionate Neurological Research – Protocol N-C7-44* with Stefan's initials at the bottom of each page.
"Your brother signed this voluntarily. He was informed of the risks. He chose to participate because he wanted his death to have meaning. I gave him that meaning. If that makes me a monster in your eyes, I accept that judgment. But I would ask you to consider an alternative perspective. The men in this facility are going to die regardless. The state has already determined that their lives are forfeit. The only question is whether their deaths will be wasted or whether they will serve a purpose. I chose purpose."
"They didn't consent to having their fear harvested like a crop."
"They consented to neurological research. The specifics of the extraction protocol are proprietary. That's standard industry practice." Coyle closed the folder and folded her hands on the desk. "I'm telling you all of this because I know why you're here. You have documents. You have a source inside HelixGen. You're planning to take this story to a publication called The Sentinel, and you believe that exposure will shut down the Thanatos Project and bring me to justice. I want to explain why that won't work."
Elena said nothing. Coyle continued.
"The Mnemexa compound has now been administered to over twelve thousand patients across the United States. Those patients have families—children, grandchildren, spouses—who have watched their loved ones return from the fog of dementia. Those families vote. They donate to political campaigns. They write op-eds praising the miracle of modern medicine. If you publish this story, you will be asking them to accept that the restoration of their loved ones' minds was purchased with the suffering of convicted murderers. Do you think they'll thank you for that revelation? Or do you think they'll vilify you for trying to take away the only treatment that gave them back their mothers and fathers?"
Elena felt her throat tighten. "It doesn't matter how they react. What you're doing is illegal."
"Is it?" Coyle's smile was faint, almost pitying. "The End-of-Life Dignity Act passed with bipartisan support. It was drafted by HelixGen's legal team, reviewed by the state attorney general's office, and signed into law by a governor who was reelected by a twelve-point margin. Every step of this protocol is legal under current statute. The classification of extraction-related fatalities as natural causes is explicitly authorized under COR-19(b). The consent forms were approved by an institutional review board. The medical waste is disposed of according to federal guidelines. We have been audited three times in the past two years. Each audit found zero violations."
"The Chimera protocol. The synthetic trigger. That's not in any consent form."
"No. It's not. It's also not yet operational. Your brother's death occurred during a standard extraction, not a Chimera trial." Coyle's voice sharpened almost imperceptibly. "And by the time you could prove otherwise, the legal framework will have caught up to the science. It always does. That's the nature of progress."
Elena understood then. Coyle was not confessing out of arrogance, though arrogance was certainly part of her makeup. She was confessing because she believed the confession didn't matter. The machine she had built was too large, too integrated, too profitable to be stopped by a single journalist with stolen documents and a ruined reputation. She was showing Elena the truth not in spite of her confidence but because of it. The truth was powerless when the system was designed to absorb it.
"You should leave now," Coyle said. "I've arranged for you to be escorted out. I would also advise you to reconsider your plans. The Sentinel's editor, Julian Riggs, has a history of financial irregularities that would make him vulnerable to a defamation suit. Your own history—the Calder Media Group verdict, the libel judgment, your disbarment from the Press Association—makes you an unreliable witness in any legal proceeding. You are attempting to fight a war with no weapons, no allies, and no credibility. I'm telling you this not as a threat but as a kindness. Go home. Grieve your brother. Let the world continue to improve without you."
Elena stood, her legs numb, her mind racing. She had come to Ironwood expecting denial, obstruction, perhaps even a veiled threat delivered by the black sedan and its unseen occupants. She had not expected the truth to be given so freely, so calmly, with the confidence of someone who knew that the truth had already been neutralized.
"I'll find a way," she said.
"Perhaps. But I doubt it will matter." Coyle returned her attention to her computer screen, the interview clearly concluded. "Officer Mathers will escort you out."
The name landed like a blow. Mathers. The woman from the viewing room. The woman the blocked voice had warned her not to trust. She was waiting in the corridor, her expression as unreadable as ever, her posture radiating the same calm efficiency Elena remembered from the morning of Stefan's death.
"This way, Ms. Voss."
As they walked through the blue corridor, past the humanitarian awards and the framed certificates, Mathers spoke in a voice so low Elena almost missed it. "The data card you received in Portmouth. It contains a tracker. That's how the sedan has been following you. Destroy it after you copy the files."
Elena stumbled, caught herself, kept walking. She didn't look at Mathers. She didn't respond. But as she passed through the final security checkpoint and into the cold winter air, her hand moved to her pocket, feeling the shape of the USB drive through the fabric of her jeans.
The black sedan was parked at the edge of the lot, its engine idling, its windows dark. She walked to her car, heart pounding, and drove away without looking back. In her rearview mirror, Ironwood's blue walls receded into the gray horizon, and the sedan followed at its patient, untroubled distance.
She had four days until Darnell Hayes was scheduled for harvest. She had a USB drive that was tracking her location. She had an editor who was already compromised, a whistleblower who might already be dead, and an adversary who had told her the truth because the truth was no longer a weapon.
And she had a single card left to play: Mathers. The woman who was not supposed to be trusted. The woman who had just risked everything to warn her.
No comments yet. Be the first to comment!